MI
ModivCare Inc (MODV)·Q3 2024 Earnings Summary
Executive Summary
- Q3 2024 service revenue rose 2.2% year over year to $702.0M; adjusted EBITDA was $43.2M (6.2% margin), while GAAP diluted EPS was -$1.87 and adjusted EPS was $0.45, reflecting lower YoY profitability on higher interest expense and debt extinguishment costs tied to refinancing the 2025 notes .
- Management affirmed FY 2024 guidance: revenue $2.7–$2.9B and adjusted EBITDA $170–$180M; reiterated expectation for >10% adjusted EBITDA growth in 2025 .
- Working capital normalized meaningfully: gross collections on contract receivables were $105M in Q3; net contract receivables fell $55M to $110M, and net contract payables decreased $40M to $47M; covenant relief was secured via a credit agreement amendment in October .
- Strategic pivot underway: shared-risk NEMT contracts shifting to fee‑for‑service through 2025 (target mix ~60% FFS/40% full‑risk), with expected price compression offset by cost efficiencies and improved cash conversion; full‑risk state contracts remain intact and renewed/extended in 2024 .
- S&P Global Wall Street consensus estimates were unavailable due to a mapping issue; no beat/miss versus consensus can be asserted. Management characterized results as “in line with expectations” .
What Went Well and What Went Wrong
- What Went Well
- Collections and working capital: $105M of gross contract receivables collected; net contract receivables down $55M QoQ to $110M and net contract payables down $40M to $47M, improving cash conversion trajectory .
- PCS growth and margin improvement: PCS revenue grew 4.7% YoY to $188.5M; adjusted EBITDA margin improved sequentially to 8.3%, with management targeting ~10% exit margin by year end .
- RPM margins strong: RPM adjusted EBITDA margin reached ~37% on sequential revenue growth; management expects mid‑30% margins going forward despite MA headwinds .
- What Went Wrong
- Profitability compression vs. prior year: Adjusted EBITDA fell to $43.2M (6.2% margin) from $51.3M (7.5%) in Q3 2023, driven by higher interest expense (+$10.6M) and $11.8M loss on debt extinguishment from refinancing .
- NEMT margin deterioration: NEMT adjusted EBITDA margin declined to 6.2% from 7.3% YoY amid trip mix and higher utilization; NEMT gross margin fell to 11.3% from 11.9% .
- MA supplemental benefits and contract mix remain headwinds: Management expects MA contraction in 2025 affecting NEMT/RPM volumes; fee‑for‑service shift entails price compression, requiring continued cost reductions to protect margins .
Financial Results
Segment breakdown (Q3 2024):
KPIs – NEMT:
KPIs – PCS:
KPIs – RPM:
Guidance Changes
Notes: 9/16 press release revised FY24 adjusted EBITDA to $170–$180M; Q3 press release affirmed that range and reiterated >10% adjusted EBITDA growth expected in 2025 .
Earnings Call Themes & Trends
Management Commentary
- “Third quarter results were in line with our expectations with adjusted EBITDA of $43 million and revenue of $702 million… We were successful in getting an amendment to our credit agreement, giving us temporary relief with our debt covenants” — CEO Heath Sampson .
- “We were able to collect gross contract receivable amounts of $105 million… and reduced our contracts receivable build by 40% on a go-forward basis through increased upfront payments” — CEO Heath Sampson .
- “We maintained our 2024 revenue guidance… and our adjusted EBITDA guidance in a range of $170 million to $180 million. We expect 2025 adjusted EBITDA to increase approximately 10%” — CFO Barbara Gutierrez .
- “In the third quarter, we realized $3 million of net cost savings… payroll and other expense per trip… down approximately 25% over the last 18 months” — CEO Heath Sampson .
Q&A Highlights
- Fee‑for‑service shift: Shared‑risk NEMT contracts are moving to fee‑for‑service with expected price compression outweighed by improved cash timing; full‑risk state contracts remain; management targets ~60% FFS/40% full‑risk exit‑2025 .
- Free cash flow conversion: Post mid‑2025, management targets ~30% EBITDA‑to‑FCF conversion; upside toward ~50% contingent on deleveraging .
- Matrix monetization: Still planned; timing pushed given MA headwinds; option remains open and prepared for execution when value/timing optimal .
- PCS exit margin: Management reiterated ~10% exit margin for 2024; rate increases (NY, NJ, WV) and operating efficiencies to support trajectory .
- Defensive position vs rideshare: Brokers manage benefit complexity and higher-acuity transport needs; deep ecosystem integrations with providers/facilities cited as differentiator .
Estimates Context
- S&P Global Wall Street consensus estimates (EPS, revenue, EBITDA) for MODV were unavailable due to a CIQ mapping issue at the time of analysis; therefore no beat/miss versus consensus is presented. Management stated Q3 was “in line with expectations” .
- If consensus becomes available, key comparison points would be: Q3 revenue $702.0M, GAAP diluted EPS -$1.87, adjusted EPS $0.45, adjusted EBITDA $43.2M .
Key Takeaways for Investors
- The quarter stabilized operationally: revenue grew modestly YoY and adjusted EPS returned to positive, while working capital metrics improved materially via collections and prepayment resets — supportive for near‑term liquidity and 2025 cash conversion normalization .
- NEMT economics are transitioning: expect continued price compression in fee‑for‑service shared‑risk contracts, offset by demonstrable unit cost reductions (purchased services and payroll/other per trip) and scale advantages; full‑risk state contracts remain resilient .
- PCS is on a margin recovery path with sequential improvements and recent rate actions in NY, NJ and WV; exit‑year EBITDA margin around 10% appears achievable if operational efficiencies continue .
- RPM margins are robust despite MA headwinds; management expects mid‑30% margins to persist, with Medicaid LTSS growth offsetting MA contraction in 2025 .
- Balance sheet and covenants: October amendment provided near‑term relief; a long‑term amendment is being pursued; deleveraging via operations and potential asset monetization (Matrix) remains a central strategic priority .
- 2024 outlook is unchanged on revenue and affirmed lower adjusted EBITDA range; 2025 setup targets >10% adjusted EBITDA growth, but investors should model MA contraction and fee‑for‑service price compression alongside cost‑out benefits .
- Tactical implication: near‑term stock catalysts likely hinge on progress toward long‑term covenant relief, visibility into fee‑for‑service conversions, PCS margin execution, and any concrete steps on Matrix monetization; monitor Q4 commentary for 2025 guidance detail .